Pascal Biosciences Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PSCBF research report →
Price Chart
About the company
Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for oncology and bolstering immune system function. The company's robust pipeline includes several key candidates: PAS-403, a potent mitosis inhibitor designed to impede cancerous cell division, specifically targeting glioblastoma and secondary brain tumors; and PAS-393, an immunomodulatory cannabinoid developed to enhance the immune system's recognition of tumor cells when utilized alongside checkpoint inhibitor therapy.
- CEO
- John Kueber
- IPO
- 2015
- Employees
- 2
- HQ
- Seattle, WA, US
Get TickerSpark's AI analysis on PSCBF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $4.20M
- P/E
- -4.32
- PEG
- -0.14
- P/S
- 0.60
- P/B
- 1.16
- EV/EBITDA
- -44.37
- Div Yield
- 0.00%
- Gross Margin
- 41.28%
- Op Margin
- -16.96%
- Net Margin
- -16.21%
- ROE
- -26.00%
- ROIC
- -22.68%
Latest fiscal year · YoY change
- Revenue
- $670.16K+0.0%
- Gross Profit
- $-345,420.86-4043.7%
- Op Income
- $-895,844.9
- Net Income
- $-398,945.11+17.4%
- EPS
- $-0.02+54.0%
- OCF Growth
- -159.1%
- FCF Growth
- -162.5%
- 52W High
- $0.15
- 52W Low
- $0.02
- 50D MA
- $0.10
- 200D MA
- $0.09
- Beta
- -0.01
- RSI (14)
- 47
- Avg Volume
- 20.43K
No earnings-call transcripts are available for PSCBF yet.
- Free Float
- 86.2%
- Shares Outstanding
- 38.14M
- Float Shares
- 32.89M
Our PSCBF coverage
Recent articles, reports, and earnings notes.
No research on PSCBF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PSCBF report →Nevis Brands Secures U.S. Trademark Registration for "MAJOR" Brand
thenewswire.com · Jul 9
Nevis Brands partners with Drecisco Farms to launch Major in Illinois
proactiveinvestors.com · Feb 5
Nevis Brands expands THC shots to new states – ICYMI
proactiveinvestors.com · Jan 11
Nevis Brands expands Major cannabis beverage sales to new states in US
proactiveinvestors.com · Jan 8
Nevis Brands targets 2025 expansion in hemp-derived cannabis beverages
proactiveinvestors.com · Dec 20
Nevis Brands signs new licensing agreements in Arizona, Ohio, and Oregon
proactiveinvestors.com · Dec 3
Nevis Brands expands Major branded cannabis beverages into Oklahoma
proactiveinvestors.com · Nov 26
Nevis Brands expands Major Shots lineup in Missouri and Washington
proactiveinvestors.com · Nov 14
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.